1 / 22

Dr: Samah Gaafar Al-shaygi

بسم الله الرحمن الرحيم. The Autonomic Nervous System (1). Dr: Samah Gaafar Al-shaygi. Central NS. Nervous system. Peripheral NS. Efferent division. Afferent division. Autonomic NS. Somatic system. enteric. parasympathetic. sympathetic. Anatomy of the ANS: Efferent neurons.

caputo
Download Presentation

Dr: Samah Gaafar Al-shaygi

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. بسم الله الرحمن الرحيم The Autonomic Nervous System (1) Dr: Samah Gaafar Al-shaygi

  2. Central NS Nervous system Peripheral NS Efferent division Afferent division Autonomic NS Somatic system enteric parasympathetic sympathetic

  3. Anatomy of the ANS: • Efferent neurons. • Afferent neurons.

  4. Cholinergic Agonist • Ach transmission has 6 steps: • Synthesis, storage, release, binding, degradation & choline recycling.

  5. Cholinergic agonist: • Direct-acting cholinergic agonist. • Indirect-acting cholinergic agonist. (anti-cholinestrase).

  6. Direct-acting cholinergic agonist: • Binds directly to cholinoceptors. • Synthetic esters of choline or natural alkaloids. • Longer action than Ach. Acetylcholine: • Has no therapeutic importance due to the multiplicity of action & the rapid inactivation. • Has both muscarinic & nicotinic activity.

  7. Action: • the heart rate, COP & the BP. • the GIT secretions & motility. • the bronchial secretion. • the tone of detrosur muscle. • leads to ciliary muscle contraction & pupilary constriction. Bethanechol: • Related structurally to ACH. • It has no nicotinic action but a strong muscarinic one.

  8. Action: • In the GIT, it increases motility & tone. • In the bladder, it stimulates the detruser muscle causing urine expulsion ( used for PO atonic bladder). A.E: • As generalized cholinergic stimulation. Carbachol: • Muscarinic & nicotinic action.

  9. Action: • On the CVS. • On the GIT. • Epinephrine release from the adrenal medulla (nicotinic action). • In the eye it causes miosis & spasm of accommodation. • is used as a miotic agent to treat glaucoma (pupilary constriction & the IOP).

  10. pilocaroine: • Less potent than Ach & it’s derivatives. • Has muscarinic activity. • Used in the eye to produce miosis & accommodation spasm. • The drug of choice in emergency lowering of the IOP. A.E: • CNS disturbances. • Profuse sweating & salivation.

  11. Reversible -anticholinestrase • They inhibit Ach-esterase so prolong the action of Ach. • Act on all cholinoceptors in the body (nicotinic & muscarinic).

  12. Physostigmine: • A tertiary amine. • intestinal & bladder motility so is used in atony. • Used in glaucoma. • To treat overdose of anti-cholinergic action as atropine. A.E: • Convulsions. • Bradycardia & COP. • Skeletal muscle paralysis (rare with therapeutic dose).

  13. Neostigmine: • A quaternary amine. • Stronger action than physo. On skeletal muscles (contraction then paralysis). • Used to stimulate the bladder & GIT, myasthenia gravis (edrophonium for Δ). A.E: • generalized cholinergic stimulation.

  14. Irreversible anticholinesterase • Are synthetic organophosphorus compound. • Extremely toxic (as pesticides). Isoflurophate: • Generalized cholinergic stimulation. • Paralysis of motor function (breathing difficulties). • Convulsions. • Intense miosis (topically to treat open-angle glaucoma) ecothiophate replace it. • Pralidoxime is an antidote (except for the CNS).

  15. Cholinergic antagonists1-Antimuscarinic • They block the muscarinic receptors inhibiting their function. Atropine: • Binds competitively. • Acts centrally & peripherally. Action: • In the eye it causes persistent mydriasis & cycloplegia. • GIT : it’s an antispasmodic.

  16. Urinary system: it decrease the bladder motility. • CVS: In low dose bradycardia (blocks M1 in the inhibitory prejunctional neurons. In higher doses HR (blocks M2 in SA node). • It blocks the salivary, lacrimal & sweat glands (as antiscretory prior to surgery). • Used as an antidote for cholinergic agonist.

  17. A.E: • Tachycardia, dry mouth, constipation, blurred vision, restlessness, confusion hallucinations & glaucoma precipitation. Scopalamine: • It has greater CNS action, longer duration, anti-motion sickness, sedation & blocks short term memory. Ipratropium: • Quaternary derivative of atropine & is positively charged. • As an inhaler in asthma & COPD.

  18. Ganglionic Blockers • Work on the nicotinic receptors in the autonomic ganglia. • Are non-depolarizing competitive blockers. • Has no selectivity for sympathetic or parasympathetic ganglia (so rarely used therapeutically only experimentally). Nicotine: • Stimulation & then paralysis of all the ganglia. • It causes transmitter release. • It BP, HR, secretions & peristalsis. • At higher doses the opposite happens due to ganglionic block.

  19. Trimethophan short acting, used as an alternative drug to lower the BP in emergency situations. Neuromuscular blocking drugs: • Either antagonist (non-depolarizing), or agonist (depolarizing). Non-depolarizing (competitive) blockers: • At low dose they compete with Ach & prevent muscle contraction (action is overcomed by e.g. cholinesterase inhibitors).

  20. At high doses, they can block the ion-channels so further weakening the NMJ transmission. • Used in surgery for muscle relaxation. • They don’t cross the BBB. • A.E: release of histamine, BP& HR, malignant hyperthermia, hyperkalemia. • Drug interactions: • Cholinesterase inhibitors overcome the action. • Halothane stabilizes their action. • Aminoglycosides antibiotics enhance the blockade by inhibiting Ach release. • Calcium -channel blockers may enhance their action.

  21. Depolarizing agents: • Act as ach, they depolarize the receptors. • The sustained depolarization renders the receptor unable to transmit further impulses, so gradual repolarization. • E.g. is succinylcholine, has a rapid onset & short duration of action so used in anesthesia & in ECT. A.E: hyperthermia & apnea.

  22. THANK YOU

More Related